Incyte (INCY) EBT (2010 - 2026)
Incyte's (INCY) quarterly EBT came in at $751.5 million in Q2 2026, up 34.68% on a YoY basis from $558.0 million in Q2 2025, and up 118.72% quarter-over-quarter from $343.6 million in Q1 2026.
Analysis
Incyte (INCY) EBT (2010 - 2026) Analysis & Trends
Incyte (INCY) has reported EBT for 17 consecutive years, with $751.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT rose 34.68% year-over-year to $751.5 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 billion (up 55.84% YoY), and the FY2025 full-year result was $1.7 billion, up 425.68% from the prior year.
- EBT climbed to $751.5 million in Q2 2026 per INCY's latest filing, from $343.6 million in the prior quarter.
- Across five years, EBT topped out at $751.5 million in Q2 2026 and bottomed at -$389.8 million in Q2 2024.
- Historically, EBT has averaged $246.6 million across 5 years, with a median of $235.2 million in 2024.
- The widest YoY moves for EBT: up 355.41% in 2024, down 240.41% in 2024.
- Over 5 years, EBT stood at $80.6 million in 2022, then soared by 236.11% to $271.0 million in 2023, then climbed by 15.78% to $313.7 million in 2024, then increased by 24.29% to $389.9 million in 2025, then jumped by 92.73% to $751.5 million in 2026.
- According to Business Quant data, EBT over the past three periods registered $751.5 million, $343.6 million, and $389.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -653.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 1.64 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -644.37 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 312.46 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 751.51 Mn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 372.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 751.51 Mn |
| Mar 31, 2026 | 343.60 Mn |
| Dec 31, 2025 | 389.94 Mn |
| Sep 30, 2025 | 482.31 Mn |
| Jun 30, 2025 | 558.01 Mn |
| Mar 31, 2025 | 234.19 Mn |
| Dec 31, 2024 | 313.72 Mn |
| Sep 30, 2024 | 156.52 Mn |
| Jun 30, 2024 | -389.78 Mn |
| Mar 31, 2024 | 236.16 Mn |
| Dec 31, 2023 | 270.96 Mn |
| Sep 30, 2023 | 233.80 Mn |
| Jun 30, 2023 | 277.60 Mn |
| Mar 31, 2023 | 51.86 Mn |
| Dec 31, 2022 | 80.62 Mn |
| Sep 30, 2022 | 148.59 Mn |
| Jun 30, 2022 | 229.38 Mn |
| Mar 31, 2022 | 70.54 Mn |
| Dec 31, 2021 | 120.02 Mn |
| Sep 30, 2021 | 209.47 Mn |